Cell Counting Market by Product (Instruments (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer), Consumables (Reagent, Assay Kits, Microplate)), End User (Pharmaceutical, Hospital, Research) - Global Forecast to 2023
“The global cell counting market is projected to grow at a CAGR of 6.8%.”
The cell counting market is expected to reach USD 12.32 billion by 2023 from an estimated USD 8.84 billion in 2018, at a CAGR of 6.8%. Growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers are some of the factors driving the growth of this market. However, the high cost of advanced cell counting systems and product recalls for instruments such as hematology analyzers are restraining the growth of this market to a certain extent.
“The consumables segment is expected to register the highest CAGR during the forecast period.”
On the basis of product, the cell counting market is segmented into consumables and instruments. The consumables segment is further subsegmented into media, sera, & reagents; assay kits; microplates; accessories; and other consumables. The consumables segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the use of various consumables in stem cell and cancer research along with growing applications in quality control procedures in various industries such as food and beverage, pharmaceutical, and biotechnology products manufacturing, and in the field of environmental monitoring and water treatment.
“The clinical & diagnostic applications segment to witness the highest growth during the forecast period.”
On the basis of application, the cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. The clinical and diagnostic applications segment is expected to witness the highest CAGR owing to the fact that various cell counting instruments are utilized in the diagnosis of cancer, blood-related disorders, infectious diseases, and HIV/AIDS. The increasing prevalence of these diseases will support the growth of this market segment.
“The hospitals segment is expected to register the highest CAGR during the forecast period.”
Based on end user, the cell counting market is segmented into research institutes, hospitals, clinical laboratories, pharmaceutical & biotechnology companies, and other end users. The hospitals segment is expected to register the highest CAGR during the forecast period. This can be attributed to the adoption of cell counting equipment for the diagnosis and treatment of several diseases along with the continuous consumption of consumables.
“APAC is projected to witness the highest growth during the forecast period.”
North America to account for the largest share of the global cell counting market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries.
Break of primary participants was as mentioned below:
By Company Type - Tier 1-45%, Tier 2-33% and Tier 3-22%
By Designation - C-level-43%, Director Level-38%, Others-19%
By Region - North America-41%, Europe-30%, Asia Pacific-23%, RoW-6%
The prominent players in the global cell counting market are Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Agilent Technologies (US), BioTek Instruments (US), Tecan Group (Switzerland), Roche Diagnostics (Switzerland), Sysmex Corporation (Japan), HORIBA, Ltd. (Japan), Abbott Laboratories (US), and Siemens Healthineers (Germany).
The report analyzes the various cell counting products and their adoption pattern. It aims at estimating the market size and future growth potential of the global cell counting market for different segments such as product, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on product portfolios offered by the top players in the global cell counting market
Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the global cell counting market
Market Development: Comprehensive information on the lucrative emerging regions by product, application, end user, and region
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global cell counting market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global cell counting market